Integration of immunotherapy into treatment of cervical cancer: Recent data and ongoing trials
Bradley J. Monk(Florida Cancer Specialists & Research Institute), Antonio González-Martı́n(Spanish Ovarian Cancer Research Group), Takayuki Enomoto(Itami City Hospital), David S.P. Tan(National University of Singapore), Xiaohua Wu(Fudan University Shanghai Cancer Center), W. Martin Kast(University of Southern California), Mary McCormack(St Mary's Hospital)
Cited by 135
Related Papers
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
|Journal of Clinical Oncology|2000|2.3k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k